Pay by Role
Israel · Salary comparison

Aerospace Engineer vs Biomedical Engineer salary

In Israel, a aerospace engineer earns about 37% more than a biomedical engineer $176,987 vs $128,839 per year.

Showing amounts in USD (USD default; source data is ILS). FX as of Mon, 13 Jul 2026 00:02:31 +0000. Convert currencies

Pays more
Engineering
Aerospace Engineer
$176,987/yr
Monthly
$14,743
Hourly
$85
Range
$119,641$247,085
10-yr outlook
+6%
Engineering
Biomedical Engineer
$128,839/yr
Monthly
$10,725
Hourly
$62
Range
$87,099$179,843
10-yr outlook
+7%

Pay range, side by side

PercentileAerospace EngineerBiomedical Engineer
Entry (10th)$119,641$87,099
25th$148,331$107,952
Median$176,987$128,839
75th$212,020$154,341
Senior (90th)$247,085$179,843

National Israel figures in ILS. Individual pay varies with experience, employer, and location.

More Engineering comparisons

Frequently asked questions

Does a aerospace engineer or biomedical engineer earn more in Israel?
A aerospace engineer earns more, at about ‏533,000 ‏₪ per year vs ‏388,000 ‏₪ for a biomedical engineer — roughly 37% (‏145,000 ‏₪) more.
What is the salary range for these roles in Israel?
A aerospace engineer typically earns ‏360,300 ‏₪–‏744,100 ‏₪, while a biomedical engineer earns ‏262,300 ‏₪–‏541,600 ‏₪ per year.
How much do these jobs pay per month in Israel?
On a monthly basis before tax, a aerospace engineer averages about ‏44,400 ‏₪ and a biomedical engineer about ‏32,300 ‏₪.
How do entry-level salaries compare?
At the 10th percentile in Israel, a aerospace engineer earns about ‏360,300 ‏₪ while a biomedical engineer earns about ‏262,300 ‏₪ per year.
How do senior-level salaries compare?
At the 90th percentile in Israel, a aerospace engineer earns about ‏744,100 ‏₪ while a biomedical engineer earns about ‏541,600 ‏₪ per year.
Are aerospace engineer and biomedical engineer similar careers?
Both roles sit in the Engineering category on Pay by Role, which is why we compare them head-to-head. Day-to-day work still differs — review each job page for skills and outlook.